Northwestern University Human Resources
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1851-01-28
- Employees
- 5K
- Market Cap
- -
Phase I/Ib Study of Nivolumab & Veliparib in Patients With Advanced Solid Tumors & Lymphoma
Phase 1
Completed
- Conditions
- Refractory Mantle Cell LymphomaAdvanced Solid NeoplasmAggressive Non-Hodgkin LymphomaRecurrent Solid NeoplasmT-Cell Non-Hodgkin LymphomaUnresectable Solid Neoplasm
- Interventions
- Other: Laboratory Biomarker AnalysisBiological: NivolumabOther: Pharmacological Study
- First Posted Date
- 2017-02-23
- Last Posted Date
- 2024-06-12
- Lead Sponsor
- Northwestern University
- Target Recruit Count
- 15
- Registration Number
- NCT03061188
- Locations
- 🇺🇸
Northwestern University, Chicago, Illinois, United States
Yttrium-90 Radioembolization for Cirrhosis-Associated Thrombocytopenia
Not Applicable
Terminated
- Conditions
- ThrombocytopeniaCirrhosis
- Interventions
- Device: TheraSphere® Yttrium-90 Glass Microspheres, BTG International Inc.
- First Posted Date
- 2017-02-23
- Last Posted Date
- 2025-02-03
- Lead Sponsor
- Northwestern University
- Target Recruit Count
- 20
- Registration Number
- NCT03059030
- Locations
- 🇺🇸
Northwestern University/Northwestern Memorial Hospital, Chicago, Illinois, United States
Promoting Early Detection of Melanoma During the Mammography Experience
Not Applicable
Completed
- Conditions
- Melanoma (Skin Cancer)
- Interventions
- Behavioral: Improve awareness of checking molesOther: Comparator
- First Posted Date
- 2017-02-20
- Last Posted Date
- 2017-10-09
- Lead Sponsor
- Northwestern University
- Target Recruit Count
- 560
- Registration Number
- NCT03057327
- Locations
- 🇺🇸
Northwestern Memorial Hospital, Chicago, Illinois, United States
PDL and Fractional Photothermolysis for Postsurgical Scars
Not Applicable
Active, not recruiting
- Conditions
- Scar
- Interventions
- Device: PDL (Pulsed Dye Laser)Device: Fractional Photothermolysis Laser
- First Posted Date
- 2017-02-20
- Last Posted Date
- 2025-01-31
- Lead Sponsor
- Northwestern University
- Target Recruit Count
- 76
- Registration Number
- NCT03057964
- Locations
- 🇺🇸
Northwestern University Feinberg School of Medicine, Department of Dermatology, Chicago, Illinois, United States
Improve PAD PERformance With METformin
Phase 3
Active, not recruiting
- Conditions
- Peripheral Artery Disease
- Interventions
- Drug: Placebo
- First Posted Date
- 2017-02-15
- Last Posted Date
- 2025-04-03
- Lead Sponsor
- Northwestern University
- Target Recruit Count
- 203
- Registration Number
- NCT03054519
- Locations
- 🇺🇸
University of Florida, Gainesville, Florida, United States
🇺🇸Northwestern University, Chicago, Illinois, United States
🇺🇸University of Chicago, Chicago, Illinois, United States
Prostatic Artery Embolization (PAE) for Treatment of Signs and Symptoms of Benign Prostatic Hyperplasia (BPH) Using Bead Block Microspheres
Not Applicable
Completed
- Conditions
- Benign Prostatic Hyperplasia (BPH)
- Interventions
- Device: Prostate Artery Embolization
- First Posted Date
- 2017-02-14
- Last Posted Date
- 2023-10-10
- Lead Sponsor
- Northwestern University
- Target Recruit Count
- 28
- Registration Number
- NCT03052049
- Locations
- 🇺🇸
Northwestern, Chicago, Illinois, United States
Asthma and Atopic Dermatitis Validation of PROMIS Pediatric Instruments
Not Applicable
Completed
- Conditions
- PsoriasisAtopic DermatitisIchthyosis
- Interventions
- Other: Stigma Questionnaire and InterviewOther: Itch Questionnaire and InterviewOther: Cognitive Interview and PROMIS Itch Questionnaire
- First Posted Date
- 2017-02-13
- Last Posted Date
- 2020-10-09
- Lead Sponsor
- Northwestern University
- Target Recruit Count
- 943
- Registration Number
- NCT03051347
- Locations
- 🇺🇸
Department of Dermatology, Northwestern University Feinberg School of Medicine and Lurie Children's Hospital, Chicago, Illinois, United States
A Strategy to Improve Implementation of LTVV for Patients w/ ARDS
Not Applicable
Withdrawn
- Conditions
- Acute Respiratory Distress Syndrome
- Interventions
- Behavioral: Multi-component LTVV implementation strategy
- First Posted Date
- 2017-02-13
- Last Posted Date
- 2020-03-06
- Lead Sponsor
- Northwestern University
- Registration Number
- NCT03051139
- Locations
- 🇺🇸
Northwestern University Feinberg School of Medicine, Chicago, Illinois, United States
The Effect of Platelet-rich Plasma in Subjects With Androgenetic Alopecia
Phase 2
Withdrawn
- Conditions
- Androgenetic Alopecia
- Interventions
- Device: Platelet Rich Plasma Prep SystemDrug: Placebo
- First Posted Date
- 2017-02-09
- Last Posted Date
- 2021-12-23
- Lead Sponsor
- Northwestern University
- Registration Number
- NCT03048461
Nivolumab and Metformin Hydrochloride in Treating Patients With Stage III-IV Non-small Cell Lung Cancer That Cannot Be Removed by Surgery
Phase 2
- Conditions
- Stage IV Non-Small Cell Lung CancerRecurrent Non-Small Cell Lung CarcinomaStage III Non-Small Cell Lung CancerStage IIIB Non-Small Cell Lung CancerStage IIIA Non-Small Cell Lung Cancer
- Interventions
- First Posted Date
- 2017-02-09
- Last Posted Date
- 2020-10-14
- Lead Sponsor
- Northwestern University
- Target Recruit Count
- 17
- Registration Number
- NCT03048500
- Locations
- 🇺🇸
Northwestern University- Lake Forest Hospital, Lake Forest, Illinois, United States
🇺🇸Northwestern University, Chicago, Illinois, United States
© Copyright 2025. All Rights Reserved by MedPath